Xanthones as inhibitors of Epstein-Barr virus activation

C Ito1, M Itoigawa, H Furukawa

  • 1Faculty of Pharmacy, Meijo University, Nagoya, Japan.

Cancer Letters
|July 9, 1999
PubMed

Insights

Researchers screened Guttiferae plant xanthones for antitumor promoter activity. Three xanthones significantly inhibited Epstein-Barr virus early antigen activation, suggesting potential as antitumor promoters.

Area of Science:

  • Natural Product Chemistry
  • Pharmacology
  • Virology

Background:

  • Epstein-Barr virus (EBV) activation is a target for antitumor promoter research.
  • Xanthones from the Guttiferae family are known for diverse biological activities.
  • Identifying novel antitumor promoters is crucial for cancer prevention and treatment strategies.

Purpose of the Study:

  • To screen xanthones from the Guttiferae family for potential antitumor promoter activity.
  • To evaluate the inhibitory effects of selected xanthones on Epstein-Barr virus early antigen (EBV-EA) activation.

Main Methods:

  • Primary screening of 20 xanthones isolated from Guttiferae plants.
  • Assay of inhibitory effects on EBV-EA activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells.

Main Results:

  • Three xanthones, 1,3,7-trihydroxy-2-(3-methyl-2-butenyl)xanthone (8), dulxanthone-B (10), and latisxanthone-C (15), demonstrated significant inhibition of EBV-EA activation.
  • Compounds 8, 10, and 15 showed notable potential as antitumor promoters.

Conclusions:

  • The screened xanthones from the Guttiferae family possess significant antitumor promoter properties.
  • Xanthones 8, 10, and 15 are identified as promising candidates for further investigation as antitumor agents.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...